The current research suggests that an increase of 1.0 ng/mL over PSA nadir at 12 months or 1.5 ng/mL over nadir at 24 months may be the most accurate PSA-based predictors for PCa recurrence after FT. This evidence concerns the gene KLK3 and posterior cortical atrophy.